Motley Fool8h agobullish
Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyGuruFocus.com4d agobullish
Novo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...MT Newswires4d agobullish
European Stocks Rally in Wednesday Trading Following US Elections; Euro Area Inflation RisesInvestor's Business Daily4d agobullish
Novo Surges 6% After Walloping Expectations On The Back Of Its GLP-1 DrugsInvestor's Business Daily4d agobullish
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 DrugsInvesting.com4d agobullish
European shares gain on Novo’s results; markets weigh U.S. midtermsInsider Monkey41d agobullish
Novo Nordisk Just Beat Lilly in a Trial. Is the Comeback Finally Taking Shape?Benzinga Private Markets41d agobullish
Anthropic Claude’s Claimed Breakthrough in Biology Faces a Major Question - Scientist Says He Had Already Studied the Enzymes for 4 YearsMotley Fool42d agobullish
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool44d agobullish
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?